The different cell-specific mechanisms of voluntary exercise and forced exercise in the nucleus accumbens

Physical inactivity is a global epidemic. People who take the initiative to exercise will feel pleasure during the exercise process and stick with it for a long time, while people who passively ask for exercise will feel pain and cannot stick with it. However, the neural mechanisms underlying volunt...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuropharmacology 2023-12, Vol.240, p.109714, Article 109714
Hauptverfasser: Gan, Yixia, Dong, Yigang, Dai, Shanghua, Shi, Haifeng, Li, Xinyi, Wang, Fanglin, Fu, Yingmei, Dong, Yi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Physical inactivity is a global epidemic. People who take the initiative to exercise will feel pleasure during the exercise process and stick with it for a long time, while people who passively ask for exercise will feel pain and cannot stick with it. However, the neural mechanisms underlying voluntary and forced exercise remain unclear. Here, we report that voluntary running increased the frequency and amplitude of miniature excitatory postsynaptic currents (mEPSC) but decreased membrane excitability in D1R-MSNs, whereas D2R-MSNs did not change in mEPSC and membrane excitability. Forced running increased the frequency of mEPSC and membrane excitability in D2R-MSNs, but D1R-MSNs did not change, which may be the mechanism by which forced exercise has a non-rewarding effect. These findings provide new insights into how voluntary and forced exercise mediate reward and non-reward effects. •Both wheel running and treadmill running activate neurons in the NAc.•Voluntary running only affected mEPSC of D1R-MSNs; Forced running only altered mEPSC of D2R-MSNs.•Voluntary running only decreased membrane excitability in D1R-MSNs, but forced running only increased membrane excitability in D2R-MSNs.
ISSN:0028-3908
1873-7064
1873-7064
DOI:10.1016/j.neuropharm.2023.109714